T2 Biosystems, Inc. (TTOO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 74.92M |
| Enterprise value | 118.21M |
| Trailing P/E | 0.04 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.36 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 16.47 |
| Enterprise value/EBITDA | -0.85 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.08 |
| 52-week change 3 | -28.71% |
| S&P500 52-week change 3 | 22.70% |
| 52-week high 3 | 70.0000 |
| 52-week low 3 | 2.6000 |
| 50-day moving average 3 | 3.8580 |
| 200-day moving average 3 | 8.6080 |
Share statistics
| Avg vol (3-month) 3 | 337.44k |
| Avg vol (10-day) 3 | 139.41k |
| Shares outstanding 5 | 17.07M |
| Implied shares outstanding 6 | 17.07M |
| Float 8 | 3.28M |
| % held by insiders 1 | 2.42% |
| % held by institutions 1 | 70.75% |
| Shares short (15 May 2024) 4 | 636.48k |
| Short ratio (15 May 2024) 4 | 1.09 |
| Short % of float (15 May 2024) 4 | 3.92% |
| Short % of shares outstanding (15 May 2024) 4 | 3.73% |
| Shares short (prior month 15 Apr 2024) 4 | 374.49k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:100 |
| Last split date 3 | 13 Oct 2023 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -611.35% |
Management effectiveness
| Return on assets (ttm) | -100.17% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 7.18M |
| Revenue per share (ttm) | 1.86 |
| Quarterly revenue growth (yoy) | -0.80% |
| Gross profit (ttm) | N/A |
| EBITDA | -45.4M |
| Net income avi to common (ttm) | -45.65M |
| Diluted EPS (ttm) | 109.9200 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 6.21M |
| Total cash per share (mrq) | 0.71 |
| Total debt (mrq) | 49.5M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.28 |
| Book value per share (mrq) | -6.85 |
Cash flow statement
| Operating cash flow (ttm) | -46.88M |
| Levered free cash flow (ttm) | -31.19M |
© 2024 Yahoo. All rights reserved.